Diagnostic and surveillance limitations and lack of treatment options, vaccines hamper efforts.
Although internet-based surveillance methods have recently been established to enhance vector-borne disease surveillance, assessment of their utility is required to determine how best to position this technology to improve infectious disease outcomes.
Researchers reported on the first outbreak of an Asian lineage of chikungunya virus in Aruba.
As a direct consequence of this trial, WHO revised its policy on long-lasting insecticidal nets in September, 2017, gave interim endorsement to pyrethroid-piperonyl butoxide nets as a new WHO class of vector control product.
In some locations, malaria incidence remained high despite high use of nets, emphasizing the need for new tools and approaches for malaria prevention if targets for the reduction of the global malaria burden are to be achieved.
Clinician suspicion shows limited accuracy in evaluating Lyme disease.
Without proactive measures and response, the changing climate is projected to continue to adversely affect the global incidence and distribution of infectious diseases and cause 250,000 additional deaths per year between 2030 and 2050.
Diagnosing Lyme disease can be difficult because symptoms vary from one person to another and can resemble symptoms of other infectious diseases spread by ticks.
Patient had an underlying medical condition and tested positive for Zika.
Because Aedes mosquitoes also transmit chikungunya and Zika viruses, there is risk for local transmission of these pathogens and a need for vector control and mosquito bite prevention strategies in the border region.
The guidelines note that physicians must request the correct diagnostic tests to confirm diagnosis, as well as completely understand the limitations and usefulness of these tests.
In addition to carrying chikungunya and dengue, female Aedes aegypti mosquitos also carry the Zika virus.
Profounda announced the launch of Impavido (miltefosine) for the treatment of visceral, mucosal, and cutaneous leishmaniasis in patients aged ≥12 years.
Agency says testing the insects in Florida Keys poses little risk to people, animals, the environment.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Practical Tips to Improve HIV/AIDS Medication Adherence
- Threat of Zika Virus Still Significant in California
- Protective Role of Pre-F Antibodies Against RSV Acute Respiratory Infection
- HCV Neuropsychiatric Symptoms Likely Linked to Virus' Effects on Brain Function
- Prenatal Tdap Vaccination Not Associated With an Increased Risk of Autism
- Evaluation of Appropriateness of Ceftriaxone Use in the Emergency Department
- Risk Factors for Prosthetic Joint Infection Increase Likelihood for Surgical Revision
- CDC: Increase in Rate of STDs for Fourth Consecutive Year in the United States
- Effect of Respiratory Tract Microbiome on Susceptibility to Viral Infections
- Gram-Negative Bacteria Antibiotic Susceptibility for Pneumonia in the ICU
- Food Insecurity Associated With Substance Use in Women Infected With HIV
- Penicillin Allergies: Commonly Reported but Rarely Accurate
- Neisseria Meningitidis Serogroup W Infections Increasing in Georgia
- Cardiac Changes Linked With Specific ARVs in Perinatally Acquired HIV
- Physical Activity Associated With Cognitive Benefits in Women Living With HIV